| P50 | author | William Rainey | Q117484435 |
| P2093 | author name string | Adina F Turcu | |
| | Juilee Rege | |
| P2860 | cites work | Inwardly rectifying potassium channels: their structure, function, and physiological roles | Q24296441 |
| | The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins | Q28235712 |
| | Genetics of Aldosterone-Producing Adenoma in Korean Patients | Q28552834 |
| | The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline | Q30277231 |
| | 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism | Q33569909 |
| | Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy? | Q33585059 |
| | A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium | Q34130908 |
| | Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension | Q34328209 |
| | Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter | Q34359244 |
| | Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. | Q34361662 |
| | Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment | Q35127256 |
| | Merging functional studies with structures of inward-rectifier K+ channels | Q35584086 |
| | A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma. | Q35661207 |
| | Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population | Q35728142 |
| | Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. | Q35760982 |
| | Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. | Q35787055 |
| | Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis | Q35872767 |
| | K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension | Q36019674 |
| | Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. | Q36134732 |
| | A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension | Q36134787 |
| | Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients | Q36152023 |
| | Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. | Q36274032 |
| | Molecular Heterogeneity in Aldosterone-Producing Adenomas | Q36716084 |
| | Primary aldosteronism: renaissance of a syndrome | Q36817162 |
| | A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism | Q36834983 |
| | Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline | Q37190775 |
| | Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype | Q37199598 |
| | Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production | Q37265290 |
| | a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. | Q37275979 |
| | Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma | Q37554806 |
| | The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes | Q37593326 |
| | Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors | Q37996386 |
| | Role of KCNJ5 in familial and sporadic primary aldosteronism | Q38066356 |
| | An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism | Q38161879 |
| | KCNJ5 Mutations: Sex, Salt and Selection | Q38632797 |
| | Novel genetic determinants of adrenal aldosterone regulation | Q38780428 |
| | Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells | Q38837852 |
| | Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice | Q38849463 |
| | Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma | Q39323249 |
| | Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma | Q40176652 |
| | Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations | Q41138997 |
| | Effect of chronic adrenocorticotropin stimulation on the excretion of 18-hydroxycortisol and 18-oxocortisol | Q41335684 |
| | Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma | Q41522115 |
| | Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance | Q42467688 |
| | The aldosterone–renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma | Q42947479 |
| | A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients | Q43565017 |
| | Hyperaldosteronism among black and white subjects with resistant hypertension | Q43662852 |
| | Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism | Q43702246 |
| | Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives | Q43744783 |
| | Urinary 18-hydroxycortisol and its relationship to the excretion of other adrenal steroids | Q44012620 |
| | High prevalence of primary aldosteronism in the Tayside hypertension clinic population. | Q44074818 |
| | Primary aldosteronism and hypertensive disease | Q44471490 |
| | Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. | Q44786929 |
| | Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study | Q46551755 |
| | Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. | Q47900762 |
| | A novel somatic mutation 145-147delETEinsK in KCNJ5 increases aldosterone production | Q49635923 |
| | Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism | Q49642879 |
| | Subtyping of Patients with Primary Aldosteronism: An Update | Q50087957 |
| | KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma | Q50088847 |
| | DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids? | Q50114128 |
| | Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. | Q51138106 |
| | Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations. | Q51452261 |
| | Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. | Q53088386 |
| | Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. | Q54327400 |
| | Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations. | Q55059444 |
| | A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension | Q55671192 |
| | KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism | Q56964322 |
| | Prevalence of Somatic Mutations in Thai Patients With Aldosterone-Producing Adrenal Adenomas | Q57132653 |
| | Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma | Q57822882 |
| | Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis | Q69809130 |
| | Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism | Q70621416 |
| | The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism | Q70660356 |
| | Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue | Q70986888 |
| | Production of 18-oxo-cortisol in subtypes of primary aldosteronism | Q71519109 |
| | High incidence of primary aldosteronism in 199 patients referred with hypertension | Q72712129 |
| | Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology | Q73866987 |
| | Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore | Q74184793 |
| | Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol | Q77549376 |
| | 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes | Q83216131 |
| | Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms) | Q84851934 |
| | Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas | Q85635204 |
| | Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas | Q86708263 |
| | Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism | Q87117432 |
| | Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? | Q87736127 |
| | Adrenal vein sampling in primary aldosteronism: towards a standardised protocol | Q87884876 |
| | 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status | Q90046447 |
| | Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans | Q90806780 |
| | Classification of microadenomas in patients with primary aldosteronism by steroid profiling | Q91091921 |
| | Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks | Q91439509 |
| | Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review | Q93090264 |
| | In situ metabolomics of aldosterone-producing adenomas | Q93105600 |
| P433 | issue | 1 | |
| P304 | page(s) | 3-13 | |
| P577 | publication date | 2020-02-01 | |
| P1433 | published in | Gland surgery | Q27724907 |
| P1476 | title | Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas | |
| P478 | volume | 9 | |